e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Airway disease-associated exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiac biomarkers and outcomes of COPD exacerbations
E. Shafuddin (Hamilton, New Zealand), C. Chang (Hamilton, New Zealand), R. Hancox (Dunedin, New Zealand)
Source:
International Congress 2019 – Airway disease-associated exacerbations
Session:
Airway disease-associated exacerbations
Session type:
Thematic Poster
Number:
4290
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Shafuddin (Hamilton, New Zealand), C. Chang (Hamilton, New Zealand), R. Hancox (Dunedin, New Zealand). Cardiac biomarkers and outcomes of COPD exacerbations. 4290
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts
Source: ERJ Open Res, 7 (1) 00531-2020; 10.1183/23120541.00531-2020
Year: 2021
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
Pulmonary biomarkers in asthma and COPD
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Predictors of exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Evaluation of markers for exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005
Hypercapnea is associated with cardiac arrhythmias in COPD
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The predictors for COPD exacerbations using remote patient monitoring
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Relationship of cardiac biomarkers in COPD to exacerbation and hyperinflation
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Impact of cardiovascular comorbidities on COPD exacerbations
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Determination of poorer outcomes using NIV in acute exacerbations of COPD
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept